PDE News and Research

RSS
UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

UCI discovery may lead to mitigation of side effects caused by erectile dysfunction drugs

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Surgically-removed tumor specimens can help quickly evaluate cancer drug efficacy

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Drug in clinical trials for Parkinson's disease offers hope for treating heart failure

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Impotence drugs may have life-prolonging effect on heart attack patients, research suggests

Impotence drugs may have life-prolonging effect on heart attack patients, research suggests

FDA approves new treatment option for patients dealing with mild to moderate eczema

FDA approves new treatment option for patients dealing with mild to moderate eczema

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

Erectile dysfunction drugs do not play role in preventing prostate cancer, study shows

Erectile dysfunction drugs do not play role in preventing prostate cancer, study shows

Hydrocortisone drug can also prevent lung damage in premature babies

Hydrocortisone drug can also prevent lung damage in premature babies

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

Drug that boosts activity in the brain's 'garbage disposal' system may slow Alzheimer's disease

Scientists identify mystery behind cell-signaling breakdown that causes heart failure

Scientists identify mystery behind cell-signaling breakdown that causes heart failure

HSP90 suggested as potential therapeutic target in PD

HSP90 suggested as potential therapeutic target in PD

Anacor Pharmaceuticals enrolls first patient in AN2728 Phase 3 trial for treatment of atopic dermatitis

Anacor Pharmaceuticals enrolls first patient in AN2728 Phase 3 trial for treatment of atopic dermatitis

COPD treatments: an interview with Professor Price, University of Aberdeen

COPD treatments: an interview with Professor Price, University of Aberdeen

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

PGI2 analogs, PDE5 inhibitors stimulate enhanced release of vasodilator ATP from human RBCs

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Sentinel lymph node biopsy for early breast cancer: an interview with Prof. Gordon Wishart, Anglia Ruskin University

Study demonstrates accuracy of non-invasive test for NASH diagnosis

Study demonstrates accuracy of non-invasive test for NASH diagnosis

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

PDE model identifies contaminants in water distribution networks

PDE model identifies contaminants in water distribution networks